Literature DB >> 9773878

Quantitative fluorescence flow cytometry: a comparison of the three techniques for direct and indirect immunofluorescence.

S Serke1, A van Lessen, D Huhn.   

Abstract

Three types of microbead calibrators available for quantitative fluorescence flow cytometry have been studied in parallel using a variety of monoclonal antibodies (MoAbs). The QIFI kit is designed for indirect immunofluorescence (IF), and both the Quantum Simply Cellular (QSC) assay and the Quanti-BRITE assay are designed for direct IF. Because of the different nature of the respective ligands, epitopes on cells versus F'ab-portions on QSC beads, large differences in titration curves for a large number of CD MoAbs were noted between QSC beads and cells. Use of the QSC assay and fluorescein isothiocyanate (FITC) and phycoerythrin (PE) conjugates of the same CD reagent revealed substantially different numbers of cellular binding sites. Numbers of cellular binding sites as determined by direct IF using the Quanti-BRITE assay and by indirect IF using the QIFI kit were similar. We also found that erythrocyte (RBC)-lysing reagents cause varying and sometimes substantial reduction in the fluorescence intensity (FI) of cells stained directly with CD34 MoAb conjugates, but the RBC-lysing reagents had no effect on the FI of cells stained indirectly with the same CD34 MoAbs. This report defines a number of variables critical for standardized quantitative flow cytometry. We conclude that the choice of calibrators, fluorochrome conjugates, staining methods, and modes of sample processing can effect the determination of cellular binding sites to MoAbs. Direct immunofluorescence using the Quanti-BRITE assay and indirect IF using the QIFI kit appear to yield comparable results for the standardized determination of numbers of cellular binding sites to MoAbs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773878     DOI: 10.1002/(sici)1097-0320(19981001)33:2<179::aid-cyto12>3.0.co;2-r

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  12 in total

1.  Analysis of competition binding between soluble and membrane-bound ligands for cell surface receptors.

Authors:  P Li; P Selvaraj; C Zhu
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  Concurrent binding to multiple ligands: kinetic rates of CD16b for membrane-bound IgG1 and IgG2.

Authors:  T E Williams; P Selvaraj; C Zhu
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

3.  Adhesive forces in embryonic stem cell cultures.

Authors:  Alicia A Blancas; Chi-Shuo Chen; Sarah Stolberg; Kara E McCloskey
Journal:  Cell Adh Migr       Date:  2011 Nov-Dec       Impact factor: 3.405

4.  Monitoring of CD63% in basophil activation test and suggested new parameters for allergy diagnosis.

Authors:  Salvatore Chirumbolo
Journal:  Inflamm Res       Date:  2011-12-29       Impact factor: 4.575

5.  Variables affecting the quantitation of CD22 in neoplastic B cells.

Authors:  Gregory A Jasper; Indu Arun; David Venzon; Robert J Kreitman; Alan S Wayne; Constance M Yuan; Gerald E Marti; Maryalice Stetler-Stevenson
Journal:  Cytometry B Clin Cytom       Date:  2010-09-24       Impact factor: 3.058

6.  bisFabs: Tools for rapidly screening hybridoma IgGs for their activities as bispecific antibodies.

Authors:  Sanket Patke; Ji Li; Peiyin Wang; Dion Slaga; Jennifer Johnston; Sunil Bhakta; Siler Panowski; Liping L Sun; Teemu Junttila; Justin M Scheer; Diego A Ellerman
Journal:  MAbs       Date:  2017-01-26       Impact factor: 5.857

7.  Dynamic quantification of antigen molecules with flow cytometry.

Authors:  A E Moskalensky; A V Chernyshev; M A Yurkin; V M Nekrasov; A A Polshchitsin; D R Parks; W A Moore; A Filatenkov; V P Maltsev; D Y Orlova
Journal:  J Immunol Methods       Date:  2015-02-14       Impact factor: 2.303

8.  Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.

Authors:  Jayalakshmi Balakrishna; Neil Basumallik; Robert Matulonis; Drake Scott; Dalia Salem; Gregory Jasper; Adrian Wiestner; Maryalice Stetler-Stevenson; Gerald Marti; Clare Sun; Constance M Yuan
Journal:  Leuk Lymphoma       Date:  2021-03-18

9.  Metformin attenuates V-domain Ig suppressor of T-cell activation through the aryl hydrocarbon receptor pathway in Melanoma: In Vivo and In Vitro Studies.

Authors:  Fawaz E Alanazi; Homood M As Sobeai; Khalid Alhazzani; Abdullah Al-Dhfyan; Musaad A Alshammari; Moureq Alotaibi; Khaled Al-Hosaini; Hesham M Korashy; Ali Alhoshani
Journal:  Saudi Pharm J       Date:  2021-12-31       Impact factor: 4.562

10.  Quantification of cell surface proteins with bispecific antibodies.

Authors:  C Panke; D Weininger; A Haas; F Schelter; T Schlothauer; S Bader; R Sircar; H P Josel; U Baer; H Burtscher; O Mundigl; M Grote; U Brinkmann; C Sustmann
Journal:  Protein Eng Des Sel       Date:  2013-08-19       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.